Literature DB >> 17922891

ACE I/D polymorphism in Korean patients with ischemic stroke and silent brain infarction.

S H Hong1, H M Park, J Y Ahn, O J Kim, T S Hwang, D Oh, N K Kim.   

Abstract

OBJECTIVES: Angiotensin-converting enzyme (ACE) polymorphism may play a role in stroke and silent brain infarction (SBI) susceptibility, but the results among the populations studied to date have not been consistent. Thus, we investigated the association between ACE genotypes and ischemic stroke and SBI in Korean patients. SUBJECTS AND METHODS: DNA samples from 237 stroke patients, 264 SBI patients and 234 age-matched controls were amplified using polymerase chain reaction to detect the ACE ins/del (I/D) polymorphism. Genotype was determined by the presence of a 490-bp band (I allele) or a 190-bp band (D allele) in agarose gel electrophoresis.
RESULTS: Odds ratios of the I/D and D/D genotypes and the overall (I/D + D/D) for the I/I genotype were significantly different between stroke patients and normal controls. However, there was no significant difference between patients with SBI and controls.
CONCLUSIONS: This study is the first report of a significant association between ACE polymorphism and ischemic stroke in the Asian population. Although no consistent associations have been found between ACE polymorphism and stroke in the populations studied to date, the ACE polymorphism may be a genetic determinant of ischemic stroke, at least in Korean patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17922891     DOI: 10.1111/j.1600-0404.2007.00932.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  8 in total

1.  An alternative method for genotyping of the ACE I/D polymorphism.

Authors:  Kimberly L Glenn; Zhi-Qiang Du; Joey C Eisenmann; Max F Rothschild
Journal:  Mol Biol Rep       Date:  2008-07-13       Impact factor: 2.316

Review 2.  Blood and CSF biomarkers in brain subcortical ischemic vascular disease: Involved pathways and clinical applicability.

Authors:  A Vilar-Bergua; I Riba-Llena; C Nafría; A Bustamante; V Llombart; P Delgado; J Montaner
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

3.  Association of ACE gene I/D polymorphism and ACE levels with hemorrhagic stroke: comparison with ischemic stroke.

Authors:  Satrupa Das; Sitara Roy; Vandana Sharma; Subhash Kaul; Akka Jyothy; Anjana Munshi
Journal:  Neurol Sci       Date:  2014-07-12       Impact factor: 3.307

Review 4.  Genetics of atherothrombotic and lacunar stroke.

Authors:  Stéphanie Debette; Sudha Seshadri
Journal:  Circ Cardiovasc Genet       Date:  2009-04

5.  Angiotensin-converting enzyme insertion/deletion polymorphism contributes to ischemic stroke risk: a meta-analysis of 50 case-control studies.

Authors:  Zhizhong Zhang; Gelin Xu; Dezhi Liu; Xinying Fan; Wusheng Zhu; Xinfeng Liu
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

6.  Assessment of two missense polymorphisms (rs4762 and rs699) of the angiotensinogen gene and stroke.

Authors:  Hyun-Kyung Park; Myung-Chun Kim; Sung-Min Kim; Dae Jean Jo
Journal:  Exp Ther Med       Date:  2012-01-11       Impact factor: 2.447

7.  Angiotensin I - Converting Enzyme Gene Polymorphism and Activity in Patients with Ischemic Stroke.

Authors:  Sanja Stankovic; Aleksandra Stankovic; Milika Asanin; Zagorka Jovanovic-Markovic; Dragan Alavantic; Nada Majkic-Singh
Journal:  EJIFCC       Date:  2011-01-03

Review 8.  Application of Single-Nucleotide Polymorphism-Related Risk Estimates in Identification of Increased Genetic Susceptibility to Cardiovascular Diseases: A Literature Review.

Authors:  Szilvia Fiatal; Róza Ádány
Journal:  Front Public Health       Date:  2018-01-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.